Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients
- 23 October 2000
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 29 (8), 790-792
- https://doi.org/10.1016/s0891-5849(00)00420-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular ComplicationsCirculation, 2000
- Vitamin E Supplementation and Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Vitamin E and heart disease:Free Radical Biology & Medicine, 2000
- Body mass index, diabetes, and C-reactive protein among U.S. adults.Diabetes Care, 1999
- Novel Inflammatory Markers of Coronary RiskCirculation, 1999
- Is Type II diabetes mellitus a disease of the innate immune system?Diabetologia, 1998
- Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy WomenCirculation, 1998
- The effects of alpha‐tocopherol on critical cells in atherogenesisCurrent Opinion in Lipidology, 1998
- The Pathophysiologic Roles of Interleukin-6 in Human DiseaseAnnals of Internal Medicine, 1998